• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Special MRI scan could identify stroke risk in people with atrial fibrillation
Atrial fibrillation is a heart rhythm disorder that affects millions of people. It can make you feel lousy. Even worse, it can cause potentially disabling or deadly strokes. A special MRI scan may — I stress the “may” — help identify people with atrial fibrillation who are at high risk of having a stroke. This could help many people with this condition to avoid taking warfarin or other clot-preventing medications for life. A normal heartbeat starts in a cluster of cells called the pacemaker. It sits in the heart’s upper right chamber (the right atrium). These cells generate a pulse of electricity that...
Source: New Harvard Health Information - April 28, 2015 Category: Consumer Health News Authors: Howard LeWine, M.D. Tags: Heart Health atrial fibrillation MRI prevention special MRI scan Stroke Stroke Risk Source Type: news

Reversing the effects of the new anti-clotting drugs
The oral anticoagulant warfarin (Coumadin) became available for prescription in 1954. This anti-clotting drug commanded national attention when President Dwight Eisenhower received the drug as part of his treatment following a heart attack. No other oral anticoagulant was successfully developed and marketed in the United States until 2010. Warfarin is a dangerous drug. Along with insulin, it is responsible for the most emergency hospitalizations due to adverse drug reactions. Whereas insulin causes low blood sugar, warfarin is notorious for the complication of major bleeding. Warfarin is plagued by hundreds of drug-drug an...
Source: New Harvard Health Information - December 9, 2015 Category: Consumer Health News Authors: Samuel Z. Goldhaber, MD Tags: Drugs and Supplements Health Heart Health Hypertension and Stroke anti-clotting coumadin deep-vein-thrombosis DVT Source Type: news

Pradaxa Fails to Prevent Recurrence After Cryptogenic Stroke Pradaxa Fails to Prevent Recurrence After Cryptogenic Stroke
Dabigatran, sold under the brand name Pradaxa by Boehringer Ingelheim to prevent stroke in people with atrial fibrillation, is no more effective than aspirin for preventing a subsequent stroke in patients who have experienced a cryptogenic stroke.Reuters Health Information
Source: Medscape Medical News Headlines - May 16, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Remember to weigh up risks and benefits of new PBS-listed anticoagulants
NPS MedicineWise is reiterating safety messages around the newer anticoagulants dabigatran (Pradaxa) and apixaban (Eliquis) following their PBS listing for preventing stroke on 1 September 2013 - and again for rivaxabaran (Xarelto) which was PBS listed in August for the same purpose. These medicines will be subsidised by the Pharmaceutical Benefits Scheme (PBS) for preventing stroke in people with non-valvular atrial fibrillation, and may offer alternatives for some people...
Source: Health News from Medical News Today - September 4, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Dabigatran Etexilate for Secondary Stroke PreventionDabigatran Etexilate for Secondary Stroke Prevention
While dabigatran has proven effective for reducing stroke risk in patients with nonvalvular atrial fibrillation, there is growing concern regarding potential adverse effects. What are the risks? Therapeutic Advances in Neurological Disorders
Source: Medscape Today Headlines - June 13, 2014 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Fewer Major Bleeds on Dabigatran vs Rivaroxaban for AF Fewer Major Bleeds on Dabigatran vs Rivaroxaban for AF
In elderly patients with nonvalvular atrial fibrillation (AF), dabigatran and rivaroxaban provide comparable protection against thromboembolic stroke but dabigatran is safer, according to a new analysis.Reuters Health Information
Source: Medscape Medical News Headlines - October 4, 2016 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news